Company Name:G1 Therapeutics Inc.
CEO: Mark A. Velleca

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: G1 Therapeutics Inc is a clinical-stage biopharmaceutical company. It engages in developing novel, small-molecule therapies to target significant unmet needs to treat cancer.


Key numbers

Market Capitalization:830186380
Shares Outstanding: 37582000
Float: 30223181
Next Earning Date:2020-02-18
TTm EPS: -2.9692
TTm Dividend Rate:
200 days moving average:25.6
50 days moving average: 24.68
One day percent Change: -6.56



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,